//fpnotebook.com/
t-PA
Aka: t-PA, tPA, Alteplase, Activase- See Also
- Dose
- Myocardial Infarction
- Bolus: 15 mg IV THEN
- Next: 0.75 mg/kg (max 50 mg) over 30 minutes THEN
- Next: 0.5 mg/kg (max 35 mg) over next 60 minutes
- Administer adjunctive Heparin concurrently
- See Thrombolysis
- Acute Ischemic Cerebrovascular Accident
- Calculate total dose: 0.9 mg/kg (max 90 mg)
- Bolus: Give 10% total dose as IV bolus over 1 minute
- Next: Give remainder of total dose over 60 minutes
- Acute Massive Pulmonary Embolus
- Myocardial Infarction
- Disadvantages (compared with other Thrombolytics)
- Cost: $1200
- Increased bleeding risk
- 3-4% greater risk of bleeding in older than age 75
- Re-occludes earlier than other Thrombolytics
- Needs Heparin concurrently and afterward
- Advantages (compared with other Thrombolytics)
- Probably reperfuses arteries earlier
- Superior in large, anterior Myocardial Infarctions
Alteplase (C0032143) |
|
|---|---|
| Definition (MSH) | A proteolytic enzyme in the serine protease family found in many tissues which converts PLASMINOGEN to FIBRINOLYSIN. It has fibrin-binding activity and is immunologically different from UROKINASE-TYPE PLASMINOGEN ACTIVATOR. The primary sequence, composed of 527 amino acids, is identical in both the naturally occurring and synthetic proteases. |
| Definition (CHV) | a kind of clot-dissolving enzyme |
| Definition (CHV) | a kind of clot-dissolving enzyme |
| Definition (CHV) | a kind of clot-dissolving enzyme |
| Definition (CHV) | a kind of clot-dissolving enzyme |
| Definition (CHV) | a kind of clot-dissolving enzyme |
| Definition (NCI_NCI-GLOSS) | A form of tissue plasminogen activator that is made in the laboratory. It helps dissolve blood clots and is used to treat heart attacks, strokes, and clots in the lungs. It is also being studied in the treatment of cancer. It is a type of systemic thrombolytic agent. |
| Definition (NCI) | A recombinant therapeutic agent which is chemically identical to or similar to endogenous tissue plasminogen activator (tPA). tPA is a serine protease which converts plasminogen to plasmin, a fibrinolytic enzyme. Upon administration, alteplase increases plasmin enzymatic activity, resulting in hyperfibrinolysis and potential dissolution of a thrombus or embolism. |
| Definition (PDQ) | A recombinant therapeutic agent which is chemically identical to or similar to endogenous tissue plasminogen activator (tPA). tPA is a serine protease which converts plasminogen to plasmin, a fibrinolytic enzyme. Upon administration, recombinant tPA increases plasmin enzymatic activity, resulting in hyperfibrinolysis and potential dissolution of a thrombus or embolism. Check for "http://www.cancer.gov/Search/ClinicalTrialsLink.aspx?id=42033&idtype=1" active clinical trials or "http://www.cancer.gov/Search/ClinicalTrialsLink.aspx?id=42033&idtype=1&closed=1" closed clinical trials using this agent. ("http://nciterms.nci.nih.gov:80/NCIBrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C39607" NCI Thesaurus) |
| Concepts | Pharmacologic Substance (T121) , Amino Acid, Peptide, or Protein (T116) , Enzyme (T126) |
| MSH | D010959 |
| SnomedCT | 391744002, 130625007, 386956006, 27638005, 387152000, 37411004, 108997009 |
| LNC | LP16891-1, MTHU019721 |
| English | Alteplase, Plasminogen Activator, Tissue, Plasminogen Activator, Tissue Type, Plasminogen Activator, Tissue-Type, Tissue Activator D 44, Tissue Activator D-44, Tissue Plasminogen Activator, Tissue Type Plasminogen Activator, Tissue-Type Plasminogen Activator, T-PA - tissue plasm activator, Tissue-type plasminogen activator, rt-PA, t-PA, recombinant tissue plasminogen activator, TPA (tissue plasminogen activator), tissue plasminogen activator, tissue plasminogen activator (medication), thrombolytics tissue plasminogen activator, TTPA, tPA (tissue plasminogen activator), alteplase, alteplase, recombinant, Tisokinase, T Plasminogen Activator, T-Plasminogen Activator, Recombinant Tissue Plasminogen Activator, Plasminogen Activator (Human Tissue-Type Protein Moiety), Tissue Plasminogen Activator [Chemical/Ingredient], t-plasminogen activator, t-pa, tpa, ALTEPLASE, EC 3.4.21.68, Alteplase - chemical (substance), T-plasminogen activator (substance), T-plasminogen activator, Alteplase - chemical, Tissue plasminogen activator preparation (substance), Plasminogen activator tissue type, Activase, r-tPA, tPA, T-PA, T-PA - tissue-type plasminogen activator, Tissue plasminogen activator, Tissue-type plasminogen activator preparation, rt-PA preparation, t-PA preparation, Alteplase (product), Alteplase (substance), Tissue plasminogen activator (substance), Tissue plasminogen activator preparation (product), Tissue plasminogen activator preparation, TPA, PLAT, ALTEPLASE,RECOMBINANT |
| Swedish | Vävnadsplasminogenaktivator |
| Czech | alteplasa, plasminogen - aktivátor tkáňového typu |
| Finnish | Kudoksen plasminogeenin aktivaattori |
| Italian | Attivatore del plasminogeno T, Attivatore del plasminogeno di tipo tissutale, tPA, Attivatore tissutale D-44, Attivatore del plasminogeno tissutale |
| Russian | ALTEPLAZA, PLAZMINOGENA TKANI AKTIVATOR, PLAZMINOGENA AKTIVATOR TKANEVOGO TIPA, АЛТЕПЛАЗА, ПЛАЗМИНОГЕНА АКТИВАТОР ТКАНЕВОГО ТИПА, ПЛАЗМИНОГЕНА ТКАНИ АКТИВАТОР |
| Japanese | プラスミノーゲン活性化物質-組織型, グルトパ注, 組織プラスミノーゲンアクチベーター, 組織プラスミノゲンアクチベーター, 組織プラスミノゲンアクチベータ, 組織型プラスミノーゲン活性化物質, アクチバシン, 組織プラスミノーゲンアクチベータ, Grtpa注, アルテプラーゼ |
| Spanish | activador del plasminógeno tisular (producto), preparado con activador del plasminógeno tisular (producto), preparado con activador del plasminógeno tisular, Activador de Plasminógeno Tipo Tisular, activador del plasminógeno - T, preparado de activador tisular del plasminógeno (sustancia), preparado de activador tisular del plasminógeno, activador del plasminógeno - T (sustancia), TPA, activador del plasminógeno hístico, activador del plasminógeno tisular (sustancia), activador del plasminógeno tisular, alteplasa (producto), alteplasa (sustancia), alteplasa, preparado de TPA, preparado de activador del plasminógeno tipo tisular, preparado de activador del plasminógeno tisular (sustancia), preparado de rt-PA, preparado de t-PA, Alteplasa, Activador de Plasminógeno T, Activador de Tejido Plasminógeno |
| French | tPA (tissue Plasminogen Activator), Activateur tissulaire du plasminogène, t-PA (t-Plasminogen Activator), Altéplase |
| Polish | t-PA, Aktywator plazminogenu tkankowy, Tkankowy aktywator plazminogenu, Alteplaza |
| Croatian | Tkivni aktivator plazminogena |
| German | Gewebe-Plasminogen-Aktivator, Gewebetyp-Plasminogen-Aktivator, Plasminogen-Aktivator, Gewebetyp, Alteplase, T-Plasminogen-Aktivator |
| Portuguese | Alteplase, Ativador de Plaminogênio T, Ativador de Plasminogênio Tecidual, Ativador de Plasminogênio Tipo Tecidual |
| Sources |
Derived from the NIH UMLS (Unified Medical Language System) |
Activase (C0701942) |
|
|---|---|
| Concepts | Pharmacologic Substance (T121) , Amino Acid, Peptide, or Protein (T116) , Enzyme (T126) |
| MSH | D010959 |
| French | Activase |
| English | activase, Alteplase Genentech Brand, Genentech Brand of Alteplase, Hoffmann La Roche Brand of Alteplase, Hoffmann-La Roche Brand of Alteplase, Activase |
| Sources |
Derived from the NIH UMLS (Unified Medical Language System) |
You are currently viewing the original 'fpnotebook.com\legacy' version of this website. Internet Explorer 8.0 and older will automatically be redirected to this legacy version.
If you are using a modern web browser, you may instead navigate to the newer desktop version of fpnotebook. Another, mobile version is also available which should function on both newer and older web browsers.
Please Contact Me as you run across problems with any of these versions on the website.